All Stories

  1. Extracellular vesicles from II trimester human amniotic fluid as paracrine conveyors counteracting oxidative stress
  2. A novel ionic model for matured and paced atrial-like human iPSC-CMs integrating I...
  3. Extracellular vesicles selective capture by peptide-functionalized hollow fiber membranes
  4. Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice
  5. Evolving Strategies for Extracellular Vesicles as Future Cardiac Therapeutics: From Macro- to Nano-Applications
  6. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology
  7. Addressing Heterogeneity in Direct Analysis of Extracellular Vesicles and Their Analogs by Membrane Sensing Peptides as Pan‐Vesicular Affinity Probes
  8. Macrophage‐derived extracellular vesicles alter cardiac recovery and metabolism in a rat heart model of donation after circulatory death
  9. Injury minimization after myocardial infarction: focus on extracellular vesicles
  10. Impact of Isolation Methods on Extracellular Vesicle Functionality In Vitro and In Vivo
  11. Intracoronary delivery of extracellular vesicles from human cardiac progenitor cells reduces infarct size in porcine acute myocardial infarction
  12. Particle profiling of EV‐lipoprotein mixtures by AFM nanomechanical imaging
  13. Cardiomyocyte-targeting exosomes from sulforaphane-treated fibroblasts affords cardioprotection in infarcted rats
  14. Extracellular Vesicles as Bridges Between Host Immune Cells and Graft Organ During Cellular Rejection
  15. A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes
  16. Plasma Extracellular Vesicles as Liquid Biopsy to Unravel the Molecular Mechanisms of Cardiac Reverse Remodeling Following Resynchronization Therapy?
  17. Fndc5/irisin-enriched extracellular vesicles: a new hormonal relay in the regular race against vascular ageing
  18. Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant
  19. Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy
  20. Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles
  21. Compositional profiling of EV-lipoprotein mixtures by AFM nanomechanical imaging
  22. Investigating the Paracrine Role of Perinatal Derivatives: Human Amniotic Fluid Stem Cell-Extracellular Vesicles Show Promising Transient Potential for Cardiomyocyte Renewal
  23. Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
  24. Supervised and unsupervised learning to define the cardiovascular risk of patients according to an extracellular vesicle molecular signature
  25. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies
  26. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles
  27. Stress-induced premature senescence is associated with a prolonged QT interval and recapitulates features of cardiac aging
  28. Extracellular Vesicle Surface Markers as a Diagnostic Tool in Transient Ischemic Attacks
  29. Characterization of Circulating Extracellular Vesicle Surface Antigens in Patients With Primary Aldosteronism
  30. Correction to: Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers
  31. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection
  32. Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
  33. Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease
  34. Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers
  35. A Changing Paradigm in Heart Transplantation: An Integrative Approach for Invasive and Non-Invasive Allograft Rejection Monitoring
  36. Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer
  37. An exosomal-carried short periostin isoform induces cardiomyocyte proliferation
  38. Insights into therapeutic products, preclinical research models and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC working group on cardiovascular regenerative and r...
  39. Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant
  40. Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia
  41. Role of cardiac progenitor cell-derived exosomes in a human model of ageing-induced cardiac dysfunction
  42. Systemic delivery of cardiac progenitor cell-derived exosomes ameliorate cardiac dysfunction induced by cancer drugs
  43. Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease
  44. An extracellular vesicle epitope profile is associated with acute myocardial infarction
  45. The swan song of dying cells
  46. Perioperative cardioprotection: back to bedside
  47. Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation
  48. Mitochondrial and mitochondrial‐independent pathways of myocardial cell death during ischaemia and reperfusion injury
  49. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes
  50. Ticagrelor Enhances Release of Anti-Hypoxic Cardiac Progenitor Cell-Derived Exosomes Through Increasing Cell Proliferation In Vitro
  51. Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform
  52. Inflammatory extracellular vesicles prompt heart dysfunction via TRL4-dependent NF-κB activation
  53. GMP-Grade Methods for Cardiac Progenitor Cells: Cell Bank Production and Quality Control
  54. EXODEVICE: Continuous Perfusion Large Scale Exosome Cultivation Bioreactor
  55. Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome
  56. Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
  57. Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
  58. Exosomal Expression of CXCR4 Targets Cardioprotective Vesicles to Myocardial Infarction and Improves Outcome after Systemic Administration
  59. Circulating blood cells and extracellular vesicles in acute cardioprotection
  60. Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method
  61. Notch pathway activation enhances cardiosphere in vitro expansion
  62. ALDH1A3 Is the Key Isoform That Contributes to Aldehyde Dehydrogenase Activity and Affects in Vitro Proliferation in Cardiac Atrial Appendage Progenitor Cells
  63. The Bioactivities of Exosomes secreted by Cardiac Progenitor Cells
  64. Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia
  65. Angiogenic activity of exosomes isolated from human pericardial fluid
  66. Exosomes: Therapy delivery tools and biomarkers of diseases
  67. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity
  68. First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential
  69. Roles of exosomes in cardioprotection
  70. Induced Pluripotent Stem (IPS) Cells to Assess the Cardioprotective and Proangiogenic Activities of Exosomes Secreted by Human Cardiac Progenitor Cells
  71. OUP accepted manuscript
  72. Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence
  73. Combination of mi RNA 499 and mi RNA 133 Exerts a Synergic Effect on Cardiac Differentiation
  74. Exosomes for Intramyocardial Intercellular Communication
  75. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension
  76. Exosomes act as intercellular carriers of proteins and miRNAs
  77. Altered functional differentiation of mesoangioblasts in a genetic myopathy
  78. Human Cardiospheres as a Source of Multipotent Stem and Progenitor Cells
  79. Prometheus’s heart: what lies beneath
  80. Prevention of Myocardial Remodeling by Chronic INaL Blockade in Pulmonary Hypertension
  81. Exosomes and Cardiomyocytes
  82. Isolation and Expansion of Adult Cardiac Stem/Progenitor Cells in the Form of Cardiospheres from Human Cardiac Biopsies and Murine Hearts
  83. Aberrant Functional Differentiation of Cardiac Precursors from a Dystrophic Mouse
  84. Induced pluripotent stem cells: progress towards a biomedical application
  85. A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization
  86. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction
  87. Cardiac Cell Therapy: The Next (Re)Generation
  88. Evidence for the Existence of Resident Cardiac Stem Cells
  89. Bone marrow‐derived cells can acquire cardiac stem cells properties in damaged heart
  90. Caffeine-induced Ca2+ signaling as an index of cardiac progenitor cells differentiation
  91. Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application
  92. c-kit cardiac progenitor cells: What is their potential?
  93. New Perspectives to Repair a Broken Heart
  94. Differentiation of human adult cardiac stem cells exposed to extremely low-frequency electromagnetic fields
  95. Stem cells in the heart: What's the buzz all about? Part 2: Arrhythmic risks and clinical studies
  96. Stem cells in the heart: What's the buzz all about?—Part 1: Preclinical considerations
  97. Ion Cyclotron Resonance as a Tool in Regenerative Medicine
  98. Endogenous Cardiac Stem Cells
  99. Extremely low frequency magnetic field induces differentiation of the human cardiac stem cells
  100. Cardiac stem cells can be generated in damaged heart from bone marrow-derived cells
  101. The levels of GFP gene expression driven by regulatory regions of the mouse kit gene discriminate between HSC and progenitors
  102. Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens
  103. Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration
  104. Cyclic Nucleotides and Neuroblastoma Differentiation
  105. Potential Role of Mycophenolate Mofetil in the Management of Neuroblastoma Patients
  106. Low levels of mycophenolic acid induce differentiation of human neuroblastoma cell lines